Columbia University: Prostatic Neoplasms trials

The registry lists 13 Prostatic Neoplasms studies with Columbia University as lead sponsor. 3 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 3Phase 2 4Phase 3 1Phase 4 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CUIMC Focal Therapy RegistryRecruitingNCT07623941
• AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad OncRecruitingNCT05351424Not applicable
• Tumor Microenvironment Analysis of Prostate Cancer MetastasisRecruitingNCT05304858
• Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate SurgeryTerminatedNCT01794936Not applicableResults posted
• Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate CancerTerminatedNCT00996502Phase 1/2Results posted
• Gadopiclenol in Contrast Enhanced MRI of the ProstateSuspendedNCT06226129Phase 4
• Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate CancerCompletedNCT04301414Early Phase 1
• 18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate CancerActive, not recruitingNCT03824275Phase 2/3
• Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based BiomarkersActive, not recruitingNCT03585114Phase 2
• Optical Tomography in Prostate CancerCompletedNCT03215992Not applicable
• Dorsal Penile Block for Post-Robotic Prostatectomy Foley DiscomfortWithdrawnNCT01565512Phase 1/2
• Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate CancerCompletedNCT01378091Phase 1
• Dissemination of Prostate Cancer Screening to PCP's in African American CommunitiesTerminatedNCT00629330Phase 4